Senvelgo RSSAuthorisedThis medicine is authorised for use in the European UnionvelagliflozinMedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on SenvelgoMore information on SenvelgoApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Senvelgo Active substance Velagliflozin L-proline monohydrate International non-proprietary name (INN) or common name velagliflozin Pharmacotherapeutic group Sodium-glucose co-transporter 2 (SGLT2) inhibitors Authorisation details EMA product number EMEA/V/C/005972 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for SenvelgoReference Number: EMA/CVMP/432172/2023 English (EN) (127.88 KB - PDF)First published: 06/10/2023ViewNews on SenvelgoMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 202419/07/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-13 March 202418/03/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023More information on SenvelgoSenvelgo - direct animal healthcare professional communication (DaHPC)This page was last updated on 23/05/2024Share this page